INHALED ALPHA1-PROTEINASE INHIBITOR THERAPY IN PATIENTS WITH CYSTIC FIBROSIS

Amit Gaggar,Junliang Chen,James F. Chmiel,Henry L. Dorkin,Patrick A. Flume,Rhonda Griffin,David P. Nichols,Scott H. Donaldson

INHALED ALPHA1-PROTEINASE INHIBITOR THERAPY IN PATIENTS WITH CYSTIC FIBROSIS

2016

Amit Gaggar
Junliang Chen
James F. Chmiel
Henry L. Dorkin
Patrick A. Flume
Rhonda Griffin
David P. Nichols
Scott H. Donaldson

Background Inhaled alpha1-proteinase inhibitor (PI) is known to reduce neutrophil elastase burden in some patients with CF. This phase 2a study was designed to test inhaled Alpha-1 HC, a new aerosolized alpha1-PI formulation, in CF patients.

Keywords:

Cystic fibrosis
Pathology
Neutrophil elastase
Alpha1-proteinase inhibitor
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations